You’re offline. This is a read only version of the page.
Contact TGA: info@tga.gov.au (link sends e-mail) | 1800 020 653 | More contact info
Translate | Subscribe
Home

Therapeutic Goods Administration (TGA)

Australian Government Department of Health

Main menu

  • Home
  • Safety information
    • Report a problem or side effect
      • Reporting adverse events involving medicines, vaccines or medical devices
      • Report an issue with packaging or storage of a medicine
      • AEMS guidance for health professionals
      • AEMS guidance for sponsors
      • Help us promote adverse event reporting: promotional resources kit
    • Alerts
      • Current year alerts
      • All alerts
    • Recalls
      • About Australian recall actions
      • Recall actions database
      • Uniform recall procedure
    • Prescription opioids
    • Medicine shortages
    • Early warning system
      • Monitoring communications
      • About the Early Warning System
      • Early Warning System: consumer questions and answers
      • Early Warning System: health professional questions and answers
    • Black Triangle Scheme
      • Black Triangle Scheme: Information for sponsors
    • Safety information & education
      • Medicines safety
      • Medical devices safety
      • Database of Adverse Event Notifications (DAEN)
    • COVID-19
    • COVID-19 treatments
      • COVID-19 treatments: Provisional determinations
      • Labels for COVID-19 treatments
      • Therapeutic Goods (Poisons Standard) (COVID-19 Treatment - GlaxoSmithKline) (Sotrovimab) Labelling Exemption 2021
      • COVID-19 treatments: Provisional registrations
      • COVID-19 treatments: Treatments undergoing evaluation
      • COVID-19 treatments: Advertising compliance
      • COVID-19 treatments: Information for consumers and health professionals
      • COVID-19 treatments: Information for sponsors (industry)
    • COVID-19 vaccines
      • COVID-19 vaccine approval process
      • Provisional registrations
      • COVID-19 vaccine safety monitoring and reporting
      • News and updates
      • COVID-19 vaccine advertising and import compliance
      • Information for consumers and health professionals
      • Information for sponsors (industry)
      • International collaboration
  • Consumers
    • Report a problem or side effect
      • Reporting adverse events involving medicines, vaccines or medical devices
    • Travelling with medicines and medical devices
      • Leaving Australia
      • Entering Australia
      • Helpful links for travellers
    • Buying medicines and medical devices online
      • Counterfeit medicines and devices
    • Can I import it?
      • Personal importation scheme
      • Medicinal cannabis: importation and the traveller's exemption
    • Medicines
      • How we regulate medicines
      • Prescription medicines
      • Complementary medicines
      • Over-the-counter (OTC) medicines
      • Vaccines
      • What's on my medicine label?
      • Accessing medicines during a medicines shortage
      • What ingredients are in my medicine?
    • Medical devices
      • Medical devices overview
      • Transvaginal (urogynaecological) surgical mesh hub
      • Breast implant hub
      • Cosmetic injections
      • Medical device cyber security
    • Advertising hub
    • Consumer information & education
      • Safety information for consumers
      • Medicines & medical devices
      • Community Q&A
      • MedSearch | Medicine information search app
      • Other web resources for consumers
      • Medicinal cannabis products
  • Health professionals
    • Report a problem or side effect
      • Reporting adverse events involving medicines, vaccines or medical devices
    • Accessing unapproved products
      • Special access scheme
      • Authorised prescribers
      • Clinical trials
      • Personal importation scheme
      • Medicine shortages: Information for Health Professionals
      • Accessing medicines during a medicine shortage
      • Medicinal cannabis
      • Nicotine e-cigarettes
    • Advertising
    • Medicines
      • Labelling changes: information for health professionals
      • Registration of medicines for the medical termination of early pregnancy
      • Product Information
      • Prescribing medicines in pregnancy database
      • Medicine Shortages Information Initiative
      • Fast track approval pathways for prescription medicines
    • Medical devices
      • Breast implant associated-anaplastic large cell lymphoma (BIA-ALCL)
      • Breast implant hub
      • Changes to labelling and regulation of hard surface disinfectants (commencing 1 April 2019)
      • Information for medical practitioners on pending up-classification of surgical mesh devices
      • Importing & supplying medical devices
      • Advice about medical devices for health professionals
    • Biologicals
      • Regulation of stem cell treatments: information for practitioners
    • Safety information
      • Medicines Safety Update
      • Medical Devices Safety Update
      • Australian Adverse Drug Reactions Bulletin
      • Medical device incident reporting & investigation scheme (IRIS) articles
      • Implanting medical devices
    • Other resources
    • Health professional information & education
      • Health professional educational materials
  • Industry
    • SME Assist
      • Basics of therapeutic goods regulation
      • SME Assist workshops and events
      • Educational videos
      • Overview of applying for market authorisation
      • Understanding ingredient requirements
      • Overview of medical devices and IVD regulation
      • Researcher considerations
      • Interactive decision tools
      • Useful resources for business and researchers
      • Case studies
      • SME Assist podcast series: ‘Navigating therapeutic goods regulation’
      • SME guidance material
    • Regulation basics
      • How therapeutic goods are regulated in Australia
      • Australian Register of Therapeutic Goods
      • Industry educational materials
      • Legislation & legislative instruments
      • Advertising hub
      • Labelling & packaging
      • Ingredients in therapeutic goods
      • Exporting therapeutic goods
      • Importing therapeutic goods
      • Clinical trials
      • Cosmetics
      • International scientific guidelines
      • Safety information for industry
      • Medicine shortages
    • Advertising therapeutic goods
      • Getting started
      • Complying with advertising requirements
      • Learning resources
      • Enforcement and outcomes
      • News and reports
      • Consultation and independent reviews
    • Prescription medicines
      • Australian Regulatory Guidelines for Prescription Medicines
      • Prescription medicines regulation basics
      • Standards and guidelines
      • Forms for prescription medicine sponsors
      • Regulatory decisions and notices
    • Over-the-counter medicines
      • OTC medicines regulation basics
      • Standards, guidelines and publications
      • Forms for OTC medicine sponsors
      • Regulatory decisions and notices
    • Complementary medicines
      • Complementary medicine regulation basics
      • Standards, guidelines and publications
      • Forms for complementary medicine sponsors
      • Complementary medicines reforms
      • Regulatory decisions and notices
    • Sunscreens
      • Sunscreens regulation basics
      • Standards, guidelines and publications
      • Sunscreen reforms
    • Medical devices & IVDs
      • Australian conformity assessment bodies
      • Determinations for Australian conformity assessment bodies
      • Face masks and COVID-19
      • Medical devices regulation basics
      • Unique Device Identification system
      • IVD medical devices regulation basics
      • Standards, guidelines and publications
      • Forms for medical device & IVD sponsors
      • Medical devices reforms
      • Regulatory decisions and notices
    • Biologicals
      • Australian Regulatory Guidelines for Biologicals
      • Regulatory framework for biologicals
      • Biological standards
      • Forms for the biologicals industry
      • Regulatory decisions and notices
    • Blood and blood components
      • Regulation of blood
      • Regulation of platelet-rich plasma (PRP), platelet-rich fibrin (PRF) and conditioned serum
      • Forms for the blood and blood components industry
    • Other therapeutic goods
      • Disinfectants, sterilants and sanitary products
      • Tampons & menstrual cups
    • Manufacturing therapeutic goods
      • Manufacturing basics
      • Manufacturing medicines
      • Manufacturing medical devices & IVDs
      • Manufacturing biologicals
      • Manufacturing blood and blood components
      • Manufacturing inspections
      • Forms for manufacturers
      • Notices for manufacturers
      • Notices about GMP clearance
      • Guidance on the management of GMP compliance signals
    • Scheduling of medicines & poisons
      • Scheduling basics
      • Scheduling committees meeting dates and decisions timeframes
      • The Poisons Standard (the SUSMP)
      • Public notices about scheduling
      • State/Territory scheduling information
  • About the TGA
    • TGA basics
      • Who we are & what we do
      • What the TGA doesn't do
      • Structure
      • TGA plans & reports
      • TGA reforms
      • Publications
      • Forms
      • Freedom of information
      • Acronyms & glossary
      • TGA Internet site
      • Social media
    • Contact the TGA
      • How can we help?
      • TGA customer service standards
      • Report a perceived breach or questionable practices
      • Website feedback or error reporting
      • Translate this website
    • Educational materials
      • For consumers
      • For health professionals
      • For industry
      • For university students
      • Education priorities 2018-19
    • Compliance and enforcement hub
      • Compliance management
      • Compliance actions and outcomes
      • News and information
      • Report a breach
    • Regulatory decisions & notices
      • Consent to import, supply or export goods that do not comply with standards
      • Cancellation requested by the sponsor - regulatory actions
      • Failure to pay annual charges - regulatory actions
      • TGA laboratory testing results
      • AUST numbers on medicine labels
      • S19A approval notices
    • Committees
      • TGA statutory advisory committees
      • Other committees
    • Employment & job vacancies
      • Working for the TGA
      • Recruitment information
      • Living in Canberra
    • Fees and payments
      • Schedule of fees and charges
      • Payment options
      • Information & notices about TGA fees & payments
      • Cost recovery implementation statements
      • Forms (fees and payments)
      • Annual Charge Exemption (ACE) scheme
    • TGA Business Services
      • TGA Business services: getting started with the TGA
      • TGA Business services - how to use the site
      • TGA Business Services forms
    • International
      • International activities
      • International cooperation
      • Use of international assessments
      • TGA international engagement strategy
      • Links to international agencies & organisations
    • TGA Internet site archive
      • Archived behind the news articles
      • Archived committee information
      • Archived consultations & reviews
      • Archived media releases
      • Archived newsletters and articles
      • Archived presentations
      • Archived regulatory decisions & notices
      • Archived TGA publications
  • News room
    • News & public notices
      • Latest news & updates
      • Media releases & statements
      • Behind the news
      • Newsletters & articles
      • Subscribe to updates
      • TGA tenders
      • TGA laboratory testing reports
    • Consultations & reviews
      • Open consultations & reviews
      • Closed consultations & reviews
      • About consultations
      • Consultation forecast
      • Medicines and Medical Devices Regulation Review
    • Events, training & presentations
      • Events & training
      • Presentations
    • Blog
      • TGA topics
This is a trial (beta) version of the DAEN - medicines, best viewed on a larger screen and Chrome Browser.
Decrease the text size Increase the text size

You are here

Home » Safety information » Safety information & education

Important information about the Database of Adverse Event Notifications (DAEN) – medicines

  • ‌Inclusion in the DAEN - medicines does not mean that the details of the event have been confirmed, or that the event has been determined to be related to a medicine or a vaccine.‌
  • We encourage people to report suspected side effects (also known as adverse events), even when it is not clear that a medicine or vaccine was the cause. These suspected side effects are listed in the DAEN - medicines and reflect the observations of the person who reported the event.
  • The TGA uses adverse event data, together with other scientific information, to identify and investigate potential safety issues for medicines and vaccines.
‌If you are experiencing an adverse event, please seek advice from a health professional as soon as possible. Do not stop, start or change the dose of your prescription medicines without talking to your doctor or pharmacist first.
‌

‌About the release of this information

While reasonable care is taken to ensure that the information is an accurate record of the adverse events reported to the TGA, we do not guarantee or warrant the accuracy, reliability, completeness or currency of the information or its usefulness in achieving any purpose.

To the fullest extent permitted by law, including but not limited to section 61A of the Therapeutic Goods Act 1989, the TGA will not be liable for any loss, damage, cost or expense incurred in or arising by reason of any person relying on this information.‌

‌Copyright restrictions apply to the DAEN - medicines.

‌

I need further information

   I have read and understand the above

  • Copyright
  • Privacy
  • Disclaimer
  • Security
  • Acronyms & glossary
  • Sitemap
  • A-Z guide
  • Contact the TGA
  • Freedom of Information

Sitemap Navigation

  • Home
  • Safety information
    • Report a problem or side effect
    • Alerts
    • Recalls
    • Prescription opioids
    • Medicine shortages
    • Early warning system
    • Black Triangle Scheme
    • Safety information & education
    • COVID-19
    • COVID-19 vaccines
    • COVID-19 treatments
    • COVID-19 tests
  • Consumers
    • Travelling with medicines and medical devices
    • Buying medicines and medical devices online
    • Can I import it?
    • Medicines
    • Medical devices
    • Advertising hub
    • Consumer information & education
  • Health professionals
    • Accessing unapproved products
    • Medicines
    • Medical devices
    • Biologicals
    • Other resources
    • Health professional information & education
    • Medicines Safety Update
  • Industry
    • SME Assist
    • Regulation basics
    • Advertising therapeutic goods
    • Prescription medicines
    • Over-the-counter medicines
    • Complementary medicines
    • Sunscreens
    • Medical devices & IVDs
    • Biologicals
    • Blood and blood components
    • Advanced therapies
    • Other therapeutic goods
    • Manufacturing therapeutic goods
    • Scheduling of medicines & poisons
  • About the TGA
    • TGA basics
    • Contact the TGA
    • Educational materials
    • Compliance and enforcement hub
    • Regulatory decisions & notices
    • Committees
    • Employment & job vacancies
    • Fees and payments
    • TGA Business Services
    • International
    • TGA Internet site archive
  • News room
    • News & public notices
    • Consultations & reviews
    • Events, training & presentations
    • Blog
    • Website redevelopment project (WRP)
  • www.australia.gov.au (link is external)
  • www.health.gov.au (link is external)
  • www.odc.gov.au (link is external)

The Therapeutic Goods Administration is part of the Health Products Regulation Group